Office of Pharmaceutical Science, CDER, FDA, Rockville, Maryland, 20857
Vinod P. Shah & Roger L. Williams
School of Pharmacy, University of Michigan, Ann Arbor, Michigan, 48109
Gordon L. Flynn
Taro Pharmaceutical, Inc., Hawthorne, New York, 10532
Avraham Yacobi
Department of Dermatology, University of California Medical Center, San Francisco, California, 94143
Howard I. Maibach
Department of Dermatology, University of Arkansas, Little Rock, Arkansas, 72205
Thomas J. Franz
Alpharma, Inc., Baltimore, Maryland, 21224
Stanley A. Kaplan
Health Protection Branch, Ottowa, Ontario, Canada, KIA-IB6
Jeff Kawamoto
Office of Clinical Pharmacology and Biopharmaceutics, OPS, CDER, FDA, Rockville, Maryland, 20857
Lawrence J. Lesko
University of Paris, Chatenay-Malabry, France
Jean-Paul Marty
L'Oreal, Clichy Cedex, France
Lynn K. Pershing
Department of Dermatology, University of Utah, Salt Lake City, Utah, 84132
Hans Schaefer
Schering-Plough Research Institute, Kenilworth, New Jersey, 07033
Joel A. Sequeira
Division of Bioequivalence, Office of Generic Drugs, OPS, CDER, FDA, Rockville, Maryland, 20855
Surendra P. Shrivastava
Division of Dermatology and Dental Products, Office of Drug Evaluation, CDER, FDA, Rockville, Maryland, 20855
Jonathan Wilkin